Other mAbs target specific proteins involved in pathogenesis of disease, such as anti-TNFα mAbs infliximab and adalimumab that are used to treat inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) (8). The gene discussed is TNF; the disease is rheumatoid arthritis.